|
1. Maximizing safe resection of low- and high-grade glioma(大限度順利地切除低級別和高級別膠質瘤)
2. Seizure Outcome After Surgical Resection of Insular Glioma(島葉膠質瘤手術切除后的癲癇預后)
3. Prioritization schema for immunotherapy clinical trials in glioblastoma(膠質母細胞瘤免疫治療臨床試驗的優(yōu)先方案)
4. Magnetic resonance analysis of malignant transformation in recurrent glioma(復發(fā)性膠質瘤惡變的磁共振分析)
5. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression(島葉膠質瘤切除術：患者發(fā)病率，存活率和腫瘤進展的評估)
6. Perioperative outcomes following reoperation for recurrent insular gliomas(復發(fā)性島葉膠質瘤再次手術后的圍手術期結局)
7. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults(脊髓室管膜瘤的手術結果以及切除范圍對兒童和青年患者的重要性)
8. Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach(鞍結節(jié)腦膜瘤：使用經顱與經蝶竇方法評估手術結果的分級量表)
9. Future directions in treatment of brain metastases(腦轉移瘤治療的未來方向)
10. Low-grade gliomas(低級別膠質瘤)
11. Glioma surgery: a century of challenge(膠質瘤手術：一個世紀的挑戰(zhàn))
12. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas(5-氨基乙酰丙酸熒光引導手術治療復發(fā)性高級別膠質瘤)
13. Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma(替莫唑胺治療復發(fā)性高級別膠質瘤7天/ 7天的II期試驗)
14. Current perspectives on neuro-oncology(神經腫瘤學研究現(xiàn)狀)
15. Evolution of management strategies for cerebral gliomas: the effects of science and technology(腦膠質瘤治療策略的演變：科學和技術的影響)
16. Translational research strategies applied to glioma therapeutics(適用于膠質瘤治療的轉化研究策略)
17. Low-grade gliomas in adults(成人低級別膠質瘤)
18. Disseminated progression of glioblastoma after treatment with bevacizumab(用貝伐單抗治療彌散性膠質母細胞瘤的進展)
19. Brain metastases of breast cancer(乳腺癌的腦轉移)
20. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment(貝伐單抗治療進展期膠質母細胞瘤患者的神經外科治療和預后)
21. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas(顱咽管瘤保守切除和輔助放射治療的優(yōu)越性)
22. Current and future strategies for treatment of glioma(膠質瘤治療的現(xiàn)在與未來展望)
23. Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas(脊髓血管母細胞瘤手術治療中暫時性動脈閉塞的外科技術)
24. Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60(60歲以上患者低級別彌漫性膠質瘤手術治療的分子特征和臨床結果)
25. Long-term seizure control outcomes after resection of gangliogliomas(神經膠質瘤切除術后長期癲癇發(fā)作的控制結果)
26. Intraoperative stimulation techniques for functional pathway preservation and glioma resection(術中刺激技術用于功能性通路保留和膠質瘤切除術)
27. Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy(小兒顱內室管膜瘤：手術，放療和化療的作用)
28. Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article(腦膜瘤切除術后發(fā)生嚴重并發(fā)癥的危險因素-臨床文章)
29. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults(成人大腦半球低級別膠質瘤的術前預后分類系統(tǒng))
30. Seizure characteristics and control following resection in 332 patients with low-grade gliomas(332例低級別膠質瘤患者的癲癇發(fā)作特點及控制) |
